Literature DB >> 33337343

Emerging roles of steroid receptor coactivators in stromal cell responses.

Aarti D Rohira1, David M Lonard1, Bert W O'Malley1.   

Abstract

Tissue parenchyma is the functional unit of an organ and all of the remaining cells within that organ collectively make up the tissue stroma. The stroma includes fibroblasts, endothelial cells, immune cells, and nerves. Interactions between stromal and epithelial cells are essential for tissue development and healing after injury. These interactions are governed by growth factors, inflammatory cytokines and hormone signaling cascades. The steroid receptor coactivator (SRC) family of proteins includes three transcriptional coactivators that facilitate the assembly of multi-protein complexes to induce gene expression in response to activation of many cellular transcription factor signaling cascades. They are ubiquitously expressed and are especially critical for the developmental function of steroid hormone responsive tissues. The SRCs are overexpressed in multiple cancers including breast, ovarian, prostate and endometrial cancers. In this review, we focus on the role of the SRCs in regulating the functions of stromal cell components responsible for angiogenesis, inflammation and cell differentiation.

Entities:  

Keywords:  hormone signaling; inflammation; steroid receptor coactivators; tissue stroma

Mesh:

Substances:

Year:  2021        PMID: 33337343      PMCID: PMC7925431          DOI: 10.1530/JOE-20-0511

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  52 in total

Review 1.  The evolving relationship of wound healing and tumor stroma.

Authors:  Deshka S Foster; R Ellen Jones; Ryan C Ransom; Michael T Longaker; Jeffrey A Norton
Journal:  JCI Insight       Date:  2018-09-20

Review 2.  The myofibroblast matrix: implications for tissue repair and fibrosis.

Authors:  Franco Klingberg; Boris Hinz; Eric S White
Journal:  J Pathol       Date:  2013-01       Impact factor: 7.996

Review 3.  Nuclear receptor coactivators: master regulators of human health and disease.

Authors:  Subhamoy Dasgupta; David M Lonard; Bert W O'Malley
Journal:  Annu Rev Med       Date:  2013-09-16       Impact factor: 13.739

Review 4.  Crosstalk between fibroblasts and inflammatory cells.

Authors:  Sophie Van Linthout; Kapka Miteva; Carsten Tschöpe
Journal:  Cardiovasc Res       Date:  2014-04-11       Impact factor: 10.787

5.  SRC-3 inhibition blocks tumor growth of pancreatic ductal adenocarcinoma.

Authors:  Xianzhou Song; Hui Chen; Chengwei Zhang; Yang Yu; Zhongyuan Chen; Han Liang; George Van Buren; Amy L McElhany; William E Fisher; David M Lonard; Bert W O'Malley; Jin Wang
Journal:  Cancer Lett       Date:  2018-11-10       Impact factor: 8.679

6.  Steroid receptor coactivator-3 is required for inhibition of neointima formation by estrogen.

Authors:  Yuhui Yuan; Lan Liao; David A Tulis; Jianming Xu
Journal:  Circulation       Date:  2002-06-04       Impact factor: 29.690

Review 7.  Steroid receptor coactivators present a unique opportunity for drug development in hormone-dependent cancers.

Authors:  Aarti D Rohira; David M Lonard
Journal:  Biochem Pharmacol       Date:  2017-04-06       Impact factor: 5.858

Review 8.  Wound repair and regeneration.

Authors:  Geoffrey C Gurtner; Sabine Werner; Yann Barrandon; Michael T Longaker
Journal:  Nature       Date:  2008-05-15       Impact factor: 49.962

Review 9.  The nuclear receptor superfamily: the second decade.

Authors:  D J Mangelsdorf; C Thummel; M Beato; P Herrlich; G Schütz; K Umesono; B Blumberg; P Kastner; M Mark; P Chambon; R M Evans
Journal:  Cell       Date:  1995-12-15       Impact factor: 41.582

Review 10.  Fibroblasts in fibrosis: novel roles and mediators.

Authors:  Ryan T Kendall; Carol A Feghali-Bostwick
Journal:  Front Pharmacol       Date:  2014-05-27       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.